Delivery Order SPE2DB24D3013-SPE2DB24FFGFP

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the U.S. government. The contract, valued at $17,132.93, is a Delivery Order with a Firm Fixed Price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $15,530.12 firm fixed-price delivery order is for the provision of REVATIO 20 MG TABLET 90S, a medication, with a completion date of June 27, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,577.60, is for the delivery of Revatio 20 mg tablets to support federal healthcare programs. The contract is a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Revatio 20 mg tablets. The contract has a ceiling value of $38,919.02 and runs through October 7, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REVATIO 20 MG tablets. The contract has a firm fixed price of $8,846.49 and an ultimate completion date of September 13, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, and medical...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product REVATIO 20 MG TABLET 90S. The $2,392.44 firm fixed-price contract has a completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $22,850.43 and a completion date of July 3, 2024. It was awarded on a Firm Fixed Price basis by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award is a Delivery Order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 tablets of the drug REVATIO 20 mg, with a ceiling value of $3,227.37 and a completion date of January 13, 2025. This is a firm fixed-price delivery order contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a $17,822.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, with a period of performance through April 16, 2024. The award does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGFP
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $18,029.89 for the supply of REVATIO 20 MG TABLET 90S. The award was made by the Defense Logistics Agency, a defense agency, and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 10:07 AM